The Consumers Health Forum has called for an enhanced focus on the central role of consumers in its submission to the Review of the National Medicines Policy.

That is a development in which CHF has played a leading part and we are now urging that this momentum is maintained in the NMP Review. The interests of the patient and consumer provide an anchor and compass when it comes to policy directions involving clinicians, industry and government.

That is why we have recommended in our submission that rather than merely including consumer-centricity as one of the principles it should be an overarching focus of the entire policy.